These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy. Hollemans E, Verhoef EI, Bangma CH, Rietbergen J, Roobol MJ, Helleman J, van Leenders GJLH. Histopathology; 2020 Apr; 76(5):755-762. PubMed ID: 31944367 [Abstract] [Full Text] [Related]
26. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth. Roobol MJ, Verbeek JFM, van der Kwast T, Kümmerlin IP, Kweldam CF, van Leenders GJLH. Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815 [Abstract] [Full Text] [Related]
29. Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma. Kweldam CF, Kümmerlin IP, Nieboer D, Verhoef EI, Steyerberg EW, Incrocci L, Bangma CH, van der Kwast TH, Roobol MJ, van Leenders GJ. Eur J Cancer; 2016 Oct; 66():26-33. PubMed ID: 27522247 [Abstract] [Full Text] [Related]
30. Intraductal Adenocarcinoma of the Prostate With Cribriform or Papillary Ductal Morphology: Rare Biopsy Cases Lacking Associated Invasive High-grade Carcinoma. Russell DH, Epstein JI. Am J Surg Pathol; 2022 Feb 01; 46(2):233-240. PubMed ID: 34619708 [Abstract] [Full Text] [Related]
31. Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma. Prendeville S, Gertner M, Maganti M, Pintilie M, Perlis N, Toi A, Evans AJ, Finelli A, van der Kwast TH, Ghai S. J Urol; 2018 Jul 01; 200(1):104-113. PubMed ID: 29408568 [Abstract] [Full Text] [Related]
34. Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set. Masoomian M, Downes MR, Sweet J, Cheung C, Evans AJ, Fleshner N, Maganti M, Van der Kwast T. Histopathology; 2019 Feb 01; 74(3):474-482. PubMed ID: 30160779 [Abstract] [Full Text] [Related]
35. Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort. Trudel D, Downes MR, Sykes J, Kron KJ, Trachtenberg J, van der Kwast TH. Eur J Cancer; 2014 Jun 01; 50(9):1610-6. PubMed ID: 24703897 [Abstract] [Full Text] [Related]
37. Gleason grade patterns in nodal metastasis and corresponding prostatectomy specimens: impact on patient outcome. Downes MR, Xu B, van der Kwast TH. Histopathology; 2019 Nov 01; 75(5):715-722. PubMed ID: 31177561 [Abstract] [Full Text] [Related]
38. Addition of cribriform pattern 4 and intraductal prostatic carcinoma into the CAPRA-S tool improves post-radical prostatectomy patient stratification in a multi-institutional cohort. Nguyen NJ, Liu K, Lajkosz K, Iczkowski KA, van der Kwast TH, Downes MR. J Clin Pathol; 2024 Feb 20. PubMed ID: 38378247 [Abstract] [Full Text] [Related]
39. Clinicopathological characteristics of glomeruloid architecture in prostate cancer. Hollemans E, Verhoef EI, Bangma CH, Rietbergen J, Osanto S, Pelger RCM, van Wezel T, van der Poel H, Bekers E, Helleman J, Roobol MJ, van Leenders GJLH. Mod Pathol; 2020 Aug 20; 33(8):1618-1625. PubMed ID: 32080350 [Abstract] [Full Text] [Related]
40. PTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcinoma). Shah RB, Shore KT, Yoon J, Mendrinos S, McKenney JK, Tian W. Prostate; 2019 Aug 20; 79(11):1267-1273. PubMed ID: 31111513 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]